EBIT (Annual)

EBIT: Income before interest and taxes.

NovoCure Limited (NVCR) had EBIT of $-153.80M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$655.35M
Net Income	$-136.23M
Cost of Goods Sold	$166.88M
Gross Profit	$488.47M
Operating Expenses	$809.15M
Operating Income	$-153.80M
Non-Operating Income/Expense	$17.55M
Pre-Tax Income	$-136.25M
Normalized Pre-Tax Income	$-136.25M
Income after Taxes	$-136.23M
Income from Continuous Operations	$-136.23M
Consolidated Net Income/Loss	$-136.23M
Normalized Income after Taxes	$-136.23M
EBIT	$-153.80M
EBITDA	$-162.41M
Weighted-Average Shares Outstanding (Basic)	111.47M
Weighted-Average Shares Outstanding (Diluted)	111.47M
Earnings per Share (EPS) (Basic)	$-1.22
Earnings per Share (EPS) (Diluted)	$-1.22
Balance Sheet Financials
Current Assets	$646.73M
Property, Plant, and Equipment	$99.67M
Long-Term Assets	$157.59M
Total Assets	$804.33M
Current Liabilities	$223.23M
Long-Term Debt	$236.69M
Long-Term Liabilities	$240.63M
Total Liabilities	$463.86M
Common Equity	$340.47M
Tangible Shareholders Equity	$340.47M
Shareholders Equity	$340.47M
Common Shares Outstanding	112.49M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-49.03M
Cash Flow from Investing Activities	$437.28M
Cash Flow from Financial Activities	$-451.34M
Beginning Cash	$166.09M
End Cash	$103.39M
Increase/Decrease in Cash	$-62.70M
Stock-Based Compensation	$104.83M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.90
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.41
Debt to Equity Ratio	0.70
Gross Margin	74.54%
Operating Margin	-23.47%
EBIT Margin	-23.47%
EBITDA Margin	-24.78%
Pre-Tax Profit Margin	-20.79%
Profit Margin	-20.79%
Free Cash Flow	$-75.68M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.81
Inventory Turnover	4.06
Receiveable Turnover	4.42
Days Sales in Receivables	82.49
Return on Equity	-40.01%
Return on Tangible Equity	-40.01%
Return on Assets	-16.94%
Return on Investments	-23.60%
Book Value Per Share	$3.03
Free Cash Flow per Share	$-0.68
Operating Cash Flow per Share	$-0.44

Data from Zacks Investment Research, Inc.